Walleye Trading
BPMC

Walleye Trading’s Blueprint Medicines BPMC Stock Holding History

Walleye Trading’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,600
Closed -$205K – 4409
2025
Q2 		$205K Buy
+1,600
New +$166K ﹤0.01% 3222
2024
Q3 		– Sell
-1,000
Closed -$108K – 4129
2024
Q2 		$108K Sell
1,000
-4,800
-83% -$480K ﹤0.01% 3350
2024
Q1 		$550K Buy
5,800
+3,900
+205% +$334K ﹤0.01% 2705
2023
Q4 		$175K Buy
+1,900
New +$123K ﹤0.01% 3860
2023
Q2 		– Sell
-8,500
Closed -$382K – 4717
2023
Q1 		$382K Buy
8,500
+4,600
+118% +$207K ﹤0.01% 3009
2022
Q4 		$171K Buy
+3,900
New +$187K ﹤0.01% 3688
2021
Q1 		– Sell
-5,600
Closed -$628K – 4818
2020
Q4 		$628K Buy
+5,600
New +$590K ﹤0.01% 2454
2020
Q2 		– Sell
-100
Closed -$6K – 4240
2020
Q1 		$6K Sell
100
-26,800
-100% -$1.72M ﹤0.01% 3779
2019
Q4 		$2.15M Buy
26,900
+2,000
+8% +$150K 0.01% 1173
2019
Q3 		$1.83M Buy
24,900
+23,600
+1,815% +$2.04M 0.02% 1127
2019
Q2 		$123K Sell
1,300
-1,200
-48% -$99K ﹤0.01% 3216
2019
Q1 		$200K Buy
+2,500
New +$185K ﹤0.01% 3027
2018
Q4 		– Sell
-5,600
Closed -$437K – 4655
2018
Q3 		$437K Sell
5,600
-6,700
-54% -$466K ﹤0.01% 3039
2018
Q2 		$781K Buy
12,300
+4,200
+52% +$334K ﹤0.01% 2366
2018
Q1 		$743K Buy
+8,100
New +$698K ﹤0.01% 2252

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's BPMC Position: Q1 2025 in Review

Walleye Trading sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 1,731 shares — an estimated $151K sold.

Walleye Trading first reported a position in BPMC in Q2 2016 and held it in 10 quarters. The position peaked at $2.03M in Q4 2023. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.

  • Walleye Trading reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 1,731 Blueprint Medicines shares in Q1 2025, an estimated $151K.
  • Walleye Trading first reported a position in Blueprint Medicines in Q2 2016 and held it in 10 quarters.
  • Walleye Trading's Blueprint Medicines position peaked at $2.03M in Q4 2023.
  • 352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.